Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |